Literature DB >> 22116452

Renal function and long-term mortality in patients with asymptomatic carotid atherosclerosis.

Matthias Hoke1, Elisabeth Pernicka, Alexander Niessner, Georg Goliasch, Jasmin Amighi, Renate Koppensteiner, Erich Minar, Wolfgang Mlekusch, Helmut Rumpold, Oswald Wagner, Martin Schillinger.   

Abstract

Renal dysfunction is a risk factor for mortality in patients with atherosclerosis. Estimated glomerular filtration rate (eGFR), cystatin C (CysC) and beta-2-microglobulin (B2M) are measures of renal function. It remains unclear, which of these parameters is the strongest predictor of outcome in patients with atherosclerosis. All-cause and cardiovascular mortality were prospectively investigated in 1,065 consecutive patients with asymptomatic carotid atherosclerosis. During a median follow-up of 6.3 years 275 patients died (25.8%), including 182 (66.2%) from cardiovascular causes. Estimated GFR, CysC and B2M were all significantly and independently associated with mortality. Inclusion of the renal parameters CysC and B2M but not of eGFR into a model with established cardiovascular risk factors improved the C-statistics significantly (p=0.0035 and 0.036, respectively; p=0.182 for eGFR). The net reclassification improvement (NRI) was 32.4% (p<0.0001) for CysC, 29% (p<0.0001) for B2M, and 16.5% (p=0.019) for eGFR. The integrated discrimination improvement (IDI) was 0.014 (p=0.0009) for CysC and 0.011 (p=0.005) for B2M while it was not significant for eGFR. Results were consistent for various subgroups with different extent of atherosclerosis. In summary, CysC and B2M were found to be independent predictors for mortality and had superior predictive value compared to eGFR in patients with asymptomatic carotid atherosclerosis. The clinical importance of these findings has to be validated in larger studies with a community-based approach.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116452     DOI: 10.1160/TH11-06-0383

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin.

Authors:  Adrienne Tin; Brad C Astor; Eric Boerwinkle; Ron C Hoogeveen; Josef Coresh; Wen Hong Linda Kao
Journal:  Hum Genet       Date:  2013-02-16       Impact factor: 4.132

2.  Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.

Authors:  Meredith C Foster; Lesley A Inker; Chi-Yuan Hsu; John H Eckfeldt; Andrew S Levey; Meda E Pavkov; Bryan D Myers; Peter H Bennett; Paul L Kimmel; Ramachandran S Vasan; Josef Coresh; Robert G Nelson
Journal:  Am J Kidney Dis       Date:  2015-03-12       Impact factor: 8.860

3.  Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.

Authors:  Meredith C Foster; Lesley A Inker; Andrew S Levey; Elizabeth Selvin; John Eckfeldt; Stephen P Juraschek; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2013-03-19       Impact factor: 8.860

4.  Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.

Authors:  Xie Qing; Wang Furong; Liu Yunxia; Zhang Jian; Wang Xuping; Gao Ling
Journal:  Cardiovasc Diabetol       Date:  2012-09-14       Impact factor: 9.951

5.  Relationship between serum cystatin-c and coronary lesion severity in coronary artery disease patients with a normal glomerular filtration rate.

Authors:  Junqiang Pan; Xifeng Sun; Pengjie Zhang; Haichao Chen; Jing Lin
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

6.  Cystatin C in Acute Coronary Syndrome.

Authors:  Moushumi Lodh; Ashok Parida; Joy Sanyal; Arunangshu Ganguly
Journal:  EJIFCC       Date:  2013-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.